Original Article: Superficial cutaneous fungal infections in tropical countries

Superficial fungal infections represent an important cause of morbidity for people worldwide, particularly in the tropics. Fungal infections affect the skin, hair, or the nails, and tend to thrive in the heat and humidity of tropical countries. Because of environmental and cultural factors unique to the tropics, the causative organisms and presentation of these infections may differ from those in industrialized countries. Treatment options include topical and systemic therapy. However, social and socioeconomic factors in developing tropical countries may necessitate different treatment approaches to achieve success.

[1]  M. Friedrich,et al.  Epidemiological trends in skin mycoses worldwide , 2008, Mycoses.

[2]  R. Antaya,et al.  White piedra in children. , 2006, Journal of the American Academy of Dermatology.

[3]  T. Rosen,et al.  Rapid treatment of tinea nigra palmaris with ciclopirox olamine gel, 0.77%. , 2006, Skinmed.

[4]  A. Nicholson,et al.  The changing pattern of Tinea capitis in Jamaica. , 2006, The West Indian medical journal.

[5]  S. Mata‐Essayag,et al.  Tinea Nigra: Report of Twelve Cases in Venezuela , 2005, Mycopathologia.

[6]  S. Tyring,et al.  Tropical dermatology: fungal tropical diseases. , 2004, Journal of the American Academy of Dermatology.

[7]  L. Severo,et al.  Tinea nigra: Report of four cases observed in Rio Grande do Sul (Brazil) and a review of Brazilian literature , 1994, Mycopathologia.

[8]  R. Schwartz,et al.  Superficial fungal infections , 2004, The Lancet.

[9]  S. Friedlander,et al.  New treatments for tinea capitis , 2004, Current opinion in infectious diseases.

[10]  R. Santos,et al.  Black piedra among the Zoró Indians from Amazônia (Brazil) , 1989, Mycopathologia.

[11]  Ak Gupta,et al.  The efficacy and safety of terbinafine in children , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  S. Khandpur,et al.  Itraconazole therapy for white piedra affecting scalp hair. , 2002, Journal of the American Academy of Dermatology.

[13]  A. Horváth,et al.  A randomized, double‐blind, parallel‐group, duration‐finding study of oral terbinafine and open‐label, high‐dose griseofulvin in children with tinea capitis due to Microsporum species , 2002, The British journal of dermatology.

[14]  V. C. Erchiga,et al.  Malassezia species in skin diseases , 2002 .

[15]  V. Crespo Erchiga,et al.  Malassezia species in skin diseases. , 2002, Current opinion in infectious diseases.

[16]  A. Gupta,et al.  Efficacy of itraconazole in the prophylactic treatment of pityriasis (tinea) versicolor. , 2002, Archives of dermatology.

[17]  D. Elston,et al.  Dermoscopy in the diagnosis of tinea nigra plantaris. , 2001, Cutis.

[18]  R. Summerbell,et al.  Therapeutic Options for the Treatment of Tinea Capitis Caused by Trichophyton Species: Griseofulvin Versus the New Oral Antifungal Agents, Terbinafine, Itraconazole, and Fluconazole , 2001, Pediatric dermatology.

[19]  T. Akiti,et al.  Dermatophytoses in children: study of 137 cases. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.

[20]  R. Cerio,et al.  A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis , 2001, The British journal of dermatology.

[21]  A. White,et al.  Tropical Infectious Diseases: Principles, Pathogens, and Practice , 2000, Annals of Internal Medicine.

[22]  B. Elewski Tinea capitis: a current perspective. , 2000, Journal of the American Academy of Dermatology.

[23]  F. Flowers,et al.  Treatment of tinea nigra with terbinafine. , 1999, Cutis.

[24]  B. Reyes,et al.  Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial. , 1998, Journal of the American Academy of Dermatology.

[25]  J. Hall,et al.  Tinea nigra palmaris: differentiation from malignant melanoma or junctional nevi. , 1998, Cutis.

[26]  Helena D. Fernandez‐Nava,et al.  Comparison of single dose 400 mg versus 10‐day 200 mg daily dose ketoconazole in the treatment of tinea versicolor , 1997, International journal of dermatology.

[27]  R. Savin Diagnosis and treatment of tinea versicolor. , 1996, The Journal of family practice.

[28]  G. S. Hoog,et al.  Cell‐surface hydrophobicity and lipolysis as essential factors in human tinea nigra , 1995, Mycoses.

[29]  L. Millikan,et al.  Superficial fungal infections in the tropics. , 1994, Dermatologic clinics.

[30]  J. Sterne,et al.  TREATMENT OF SUPERFICIAL MYCOSES IN THE TROPICS: WHITFIELD'S OINTMENT VERSUS CLOTRIMAZOLE , 1994, International journal of dermatology.

[31]  H. Mittag The fine structure of Hortaea werneckii , 1993, Mycoses (Berlin).

[32]  Burke Wa Tinea nigra: treatment with topical ketoconazole. , 1993 .

[33]  R. Hay Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions. , 1993, Journal of the American Academy of Dermatology.

[34]  W. Burke Tinea nigra: treatment with topical ketoconazole. , 1993, Cutis.

[35]  J. Nyawalo,et al.  Single Dose and Intermittent Griseofulvin Regimens in the Treatment of Tinea Capitis in Kenya/Einmalbehandlung und intermittierende Therapiestrategien bei der Griseofulvin‐Behandlung der Tinea capitis in Kenya , 1988, Mycoses.

[36]  B. Davis,et al.  Treatment of tinea nigra palmaris with miconazole. , 1980, Archives of dermatology.

[37]  J. Faergemann,et al.  Propylene glycol in the treatment of tinea versicolor. , 1980, Acta dermato-venereologica.

[38]  Y. Clayton,et al.  Comparison of clotrimazole cream, Whitfield's ointment and Nystatin ointment for the topical treatment of ringworm infections, pityriasis versicolor, erythrasma and candidiasis , 1973, The British journal of dermatology.

[39]  A. T. Londero,et al.  White piedra of unusual localization. , 1967, Sabouraudia.

[40]  Paulo Horta Sobre uma nova forma de Piedra , 1911 .